-
Baxter Beats on EPS, Net Dips - Analyst Blog
Thursday, January 27, 2011 - 2:30pm | 1075Baxter International (BAX) reported fourth quarter and fiscal 2010 adjusted (excluding one-time items) earnings per share of $1.11 and $3.98, respectively, thereby beating the corresponding Zacks Consensus Estimates of $1.10 cents and $3.97, and surpassing the year-ago results of $1.03 and $3.80...
-
Deutsche Bank Takes First Look At Zimmer Holdings Q4 2010, 2011 Guidance (ZMH)
Thursday, January 27, 2011 - 1:23pm | 116Deutsche Bank took a first look at Zimmer Holdings (NYSE: ZMH) Q4 2010 and 2011 guidance in a research report published today. In the report, Deutsch Bank states, "4Q10 sales and EPS better than expected. 2011 sales guidance looks in line with Consensus and EPS guidance brackets Consensus BUT it's...
-
Goodwill Charges slash ZMH's Profit - Analyst Blog
Thursday, January 27, 2011 - 12:01pm | 541Zimmer Holdings (ZMH) reported an EPS of 18 cents during the fourth quarter of fiscal 2010, 76% lower than 74 cents in the year-ago quarter. However, after considering certain adjustments, the EPS was $1.27, surpassing the Zacks Consensus Estimate of $1.19 and $1.12 in the fourth quarter of...
-
Goodwill Charges slash ZMH's Profit - Analyst Blog
Thursday, January 27, 2011 - 11:45am | 541Zimmer Holdings (ZMH) reported an EPS of 18 cents during the fourth quarter of fiscal 2010, 76% lower than 74 cents in the year-ago quarter. However, after considering certain adjustments, the EPS was $1.27, surpassing the Zacks Consensus Estimate of $1.19 and $1.12 in the fourth quarter of...
-
Options Brief: Covidien (COV)
Thursday, January 27, 2011 - 11:23am | 75Shares of Covidien (NYSE: COV) are higher on the session by 1.15%, trading at $48.19. Overall call volume is now running at 3.04x the daily average, with 16% of all calls traded being purchases on the offer. 3,654 contracts have traded on the session so far. Covidien Public Limited Company,...
-
Company News for January 27, 2011 - Corporate Summary
Thursday, January 27, 2011 - 11:01am | 627• Qualcomm (NASDAQ:QCOM) reported Q1 EPS of $0.82, ex-items, ahead of the Zacks Consensus Estimate of $0.63 per share. Revenues for the quarter rose 25% year-over-year to $3.35 billion, above the Zacks Consensus Estimate of $3.139 billion • Starbucks (NASDAQ:SBUX) reported Q1 EPS of $0.45, above...
-
Deutsche Bank Comments on Baxter International's 2011 Guidance (BAX)
Thursday, January 27, 2011 - 10:55am | 145Deutsche Bank is out with its report today on Baxter Intl. (NYSE: BAX), commenting on BAX's 2011 guidance. In a note to clients, Deutsche Bank writes, "BAX guided to 2-3% constant currency (DB at 2.5%), ex- divestitures and FX its 4%-5%. However, EPS is below at $4.15-$4.25 (up 4%-7%) v FC at $4.23...
-
Company News for January 27, 2011 - Corporate Summary
Thursday, January 27, 2011 - 10:30am | 627• Qualcomm (NASDAQ:QCOM) reported Q1 EPS of $0.82, ex-items, ahead of the Zacks Consensus Estimate of $0.63 per share. Revenues for the quarter rose 25% year-over-year to $3.35 billion, above the Zacks Consensus Estimate of $3.139 billion • Starbucks (NASDAQ:SBUX) reported Q1 EPS of $0.45, above...
-
Jefferies Raises Price Target on Covidien (COV)
Thursday, January 27, 2011 - 10:25am | 134Jefferies is out with a research report this morning, where it reiterates its Buy rating on Covidien (NYSE: COV); it has a $56.00 price target on the stock, up from $52.00. The Jefferies analysts noted that synergies, easy comparables, and significant FCF flexibility provide Covidien favorable...
-
J.P. Morgan Reiterates St. Jude Medical Overweight Rating (STJ)
Thursday, January 27, 2011 - 9:55am | 152J.P. Morgan reiterated its St. Jude Medical (NYSE: STJ) Overweight rating in a research report published today. J.P. Morgan maintained its St. Jude Medical price target of $52, set in December 2010. In the report, J.P. Morgan states, "St. Jude reported its full 4Q results Wednesday before the open...
-
Deutsche Bank Maintains Hold on St. Jude Medical (STJ)
Thursday, January 27, 2011 - 9:36am | 120Deutsche Bank is out with its report today on St. Jude Medical (NYSE: STJ), maintaining Hold and a $45 price target. In its report, Deutsche Bank notes, "STJ's 2011 sales growth goals of 10%-13% (6%-9% organic) was above Consensus, but market seemed disappointed by 8%-10% EPS growth target. Higher...
-
Jefferies Raises COV Target To $56 From $52
Thursday, January 27, 2011 - 8:13am | 18Jefferies is raising its PT on Covidien (NYSE: COV) $56 from $52.
-
Baxter Reports Q4 EPS of $1.11
Thursday, January 27, 2011 - 8:08am | 57Baxter International Inc (NYSE: BAX) reports its Q4 adjusted EPS at $1.11, versus the consensus of $1.10. BAX reports its Q4 revenue at $3.5 billion, versus the estimates of $3.46 billion. BAX shares gained 0.20% to $51.00 in after-hours trading. Read more from Benzinga's Company news.
-
S&P Announces Index Changes (COV, MFE)
Wednesday, January 26, 2011 - 6:25pm | 93Standard & Poors just announced a changed to its S&P 500 index. Covidien (NYSE: COV) is entering the prestigious index in place of McAfee (NYSE: MFE) which is being acquired by Intel (NASDAQ: INTC). Shares of Covidien are higher in the after hours market, gaining $2.51 to $50.35, a gain of...
-
Covidien Will Replace McAfee In S&P 500 (COV, MFE)
Wednesday, January 26, 2011 - 6:24pm | 28Covidien (NYSE: COV) Will Replace McAfee (NYSE: MFE) In S&P 500 index.